BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.

Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in an opinion ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Bristol Myers Squibb has appointment Cari Gallman as executive vice president, general counsel and chief policy officer, ...

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 ...

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

Princeton: Bristol Myers Squibb has announced the appointment of Cari Gallman as Executive Vice President, General Counsel ...

Jeremy Walsh is now heading up artificial intelligence and information technology in a newly created position at the FDA.